▶ 調査レポート

世界の標識ヌクレオチド市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Labeled Nucleotides Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の標識ヌクレオチド市場 2021:企業別、地域別、種類・用途別 / Global Labeled Nucleotides Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-2104Z08088資料のイメージです。• レポートコード:GIR-2104Z08088
• 出版社/出版日:GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療・医薬品
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、標識ヌクレオチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。標識ヌクレオチドの種類別市場規模(TaqMan対立遺伝子識別、遺伝子チップ・マイクロアレイ、パイロシーケンシングSNP)、用途別市場規模(病院研究所、参照研究所、学術研究所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・標識ヌクレオチドの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Jena Bioscience、Yumpu、CJ CheilJedang Corporation、Star Lake Bioscience、ThermoFisher Scientific、Meihua Group、F. Hoffmann-La Roche、Biorigin、DSM Nutritional Products、Promega Corporation、Affymetrix、Agilent Technologies、Lallemand、Nanjing BioTogether
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:TaqMan対立遺伝子識別、遺伝子チップ・マイクロアレイ、パイロシーケンシングSNP
・用途別分析2016年-2026年:病院研究所、参照研究所、学術研究所、その他
・標識ヌクレオチドの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・標識ヌクレオチドのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・標識ヌクレオチドのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・標識ヌクレオチドの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・標識ヌクレオチドの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Labeled Nucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Labeled Nucleotides size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Labeled Nucleotides market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Labeled Nucleotides market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
TaqMan Allelic Discrimination
Gene Chips & Microarrays
SNP by Pyrosequencing

Market segment by Application can be divided into
Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other Laboratories

The key market players for global Labeled Nucleotides market are listed below:
Jena Bioscience
Yumpu
CJ CheilJedang Corporation
Star Lake Bioscience
ThermoFisher Scientific
Meihua Group
F. Hoffmann-La Roche
Biorigin
DSM Nutritional Products
Promega Corporation
Affymetrix
Agilent Technologies
Lallemand
Nanjing BioTogether

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Labeled Nucleotides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Labeled Nucleotides Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 TaqMan Allelic Discrimination
1.2.3 Gene Chips & Microarrays
1.2.4 SNP by Pyrosequencing
1.3 Market Analysis by Application
1.3.1 Overview: Global Labeled Nucleotides Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Laboratories
1.3.3 Reference Laboratories
1.3.4 Academic Research Laboratories
1.3.5 Other Laboratories
1.4 Global Labeled Nucleotides Market Size & Forecast
1.4.1 Global Labeled Nucleotides Sales in Value (2016-2026))
1.4.2 Global Labeled Nucleotides Sales in Volume (2016-2026)
1.4.3 Global Labeled Nucleotides Price by Type (2016-2026) & (USD/MT)
1.5 Global Labeled Nucleotides Production Capacity Analysis
1.5.1 Global Labeled Nucleotides Total Production Capacity (2016-2026)
1.5.2 Global Labeled Nucleotides Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Labeled Nucleotides Market Drivers
1.6.2 Labeled Nucleotides Market Restraints
1.6.3 Labeled Nucleotides Trends Analysis
2 Manufacturers Profiles
2.1 Jena Bioscience
2.1.1 Jena Bioscience Details
2.1.2 Jena Bioscience Major Business
2.1.3 Jena Bioscience Labeled Nucleotides Product and Services
2.1.4 Jena Bioscience Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Yumpu
2.2.1 Yumpu Details
2.2.2 Yumpu Major Business
2.2.3 Yumpu Labeled Nucleotides Product and Services
2.2.4 Yumpu Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CJ CheilJedang Corporation
2.3.1 CJ CheilJedang Corporation Details
2.3.2 CJ CheilJedang Corporation Major Business
2.3.3 CJ CheilJedang Corporation Labeled Nucleotides Product and Services
2.3.4 CJ CheilJedang Corporation Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Star Lake Bioscience
2.4.1 Star Lake Bioscience Details
2.4.2 Star Lake Bioscience Major Business
2.4.3 Star Lake Bioscience Labeled Nucleotides Product and Services
2.4.4 Star Lake Bioscience Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 ThermoFisher Scientific
2.5.1 ThermoFisher Scientific Details
2.5.2 ThermoFisher Scientific Major Business
2.5.3 ThermoFisher Scientific Labeled Nucleotides Product and Services
2.5.4 ThermoFisher Scientific Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Meihua Group
2.6.1 Meihua Group Details
2.6.2 Meihua Group Major Business
2.6.3 Meihua Group Labeled Nucleotides Product and Services
2.6.4 Meihua Group Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 F. Hoffmann-La Roche
2.7.1 F. Hoffmann-La Roche Details
2.7.2 F. Hoffmann-La Roche Major Business
2.7.3 F. Hoffmann-La Roche Labeled Nucleotides Product and Services
2.7.4 F. Hoffmann-La Roche Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Biorigin
2.8.1 Biorigin Details
2.8.2 Biorigin Major Business
2.8.3 Biorigin Labeled Nucleotides Product and Services
2.8.4 Biorigin Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 DSM Nutritional Products
2.9.1 DSM Nutritional Products Details
2.9.2 DSM Nutritional Products Major Business
2.9.3 DSM Nutritional Products Labeled Nucleotides Product and Services
2.9.4 DSM Nutritional Products Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Promega Corporation
2.10.1 Promega Corporation Details
2.10.2 Promega Corporation Major Business
2.10.3 Promega Corporation Labeled Nucleotides Product and Services
2.10.4 Promega Corporation Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Affymetrix
2.11.1 Affymetrix Details
2.11.2 Affymetrix Major Business
2.11.3 Affymetrix Labeled Nucleotides Product and Services
2.11.4 Affymetrix Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Agilent Technologies
2.12.1 Agilent Technologies Details
2.12.2 Agilent Technologies Major Business
2.12.3 Agilent Technologies Labeled Nucleotides Product and Services
2.12.4 Agilent Technologies Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Lallemand
2.13.1 Lallemand Details
2.13.2 Lallemand Major Business
2.13.3 Lallemand Labeled Nucleotides Product and Services
2.13.4 Lallemand Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Nanjing BioTogether
2.14.1 Nanjing BioTogether Details
2.14.2 Nanjing BioTogether Major Business
2.14.3 Nanjing BioTogether Labeled Nucleotides Product and Services
2.14.4 Nanjing BioTogether Labeled Nucleotides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Labeled Nucleotides Sales by Manufacturer
3.1 Global Labeled Nucleotides Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Labeled Nucleotides Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Labeled Nucleotides
3.4 Market Concentration Rate
3.4.1 Top 3 Labeled Nucleotides Manufacturer Market Share
3.4.2 Top 6 Labeled Nucleotides Manufacturer Market Share
3.5 Global Labeled Nucleotides Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Labeled Nucleotides Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Labeled Nucleotides Market Size by Region
4.1.1 Global Labeled Nucleotides Sales in Volume by Region (2016-2026)
4.1.2 Global Labeled Nucleotides Revenue by Region (2016-2026)
4.2 North America Labeled Nucleotides Revenue (2016-2026)
4.3 Europe Labeled Nucleotides Revenue (2016-2026)
4.4 Asia-Pacific Labeled Nucleotides Revenue (2016-2026)
4.5 South America Labeled Nucleotides Revenue (2016-2026)
4.6 Middle East and Africa Labeled Nucleotides Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Labeled Nucleotides Sales in Volume by Type (2016-2026)
5.2 Global Labeled Nucleotides Revenue by Type (2016-2026)
5.3 Global Labeled Nucleotides Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Labeled Nucleotides Sales in Volume by Application (2016-2026)
6.2 Global Labeled Nucleotides Revenue by Application (2016-2026)
6.3 Global Labeled Nucleotides Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Labeled Nucleotides Sales by Type (2016-2026)
7.2 North America Labeled Nucleotides Sales by Application (2016-2026)
7.3 North America Labeled Nucleotides Market Size by Country
7.3.1 North America Labeled Nucleotides Sales in Volume by Country (2016-2026)
7.3.2 North America Labeled Nucleotides Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Labeled Nucleotides Sales by Type (2016-2026)
8.2 Europe Labeled Nucleotides Sales by Application (2016-2026)
8.3 Europe Labeled Nucleotides Market Size by Country
8.3.1 Europe Labeled Nucleotides Sales in Volume by Country (2016-2026)
8.3.2 Europe Labeled Nucleotides Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Labeled Nucleotides Sales by Type (2016-2026)
9.2 Asia-Pacific Labeled Nucleotides Sales by Application (2016-2026)
9.3 Asia-Pacific Labeled Nucleotides Market Size by Region
9.3.1 Asia-Pacific Labeled Nucleotides Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Labeled Nucleotides Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Labeled Nucleotides Sales by Type (2016-2026)
10.2 South America Labeled Nucleotides Sales by Application (2016-2026)
10.3 South America Labeled Nucleotides Market Size by Country
10.3.1 South America Labeled Nucleotides Sales in Volume by Country (2016-2026)
10.3.2 South America Labeled Nucleotides Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Labeled Nucleotides Sales by Type (2016-2026)
11.2 Middle East & Africa Labeled Nucleotides Sales by Application (2016-2026)
11.3 Middle East & Africa Labeled Nucleotides Market Size by Country
11.3.1 Middle East & Africa Labeled Nucleotides Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Labeled Nucleotides Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Labeled Nucleotides Typical Distributors
12.3 Labeled Nucleotides Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Labeled Nucleotides Revenue by Type, (USD Million), 2021-2026
Table 2. Global Labeled Nucleotides Revenue by Application, (USD Million), 2021-2026
Table 3. Jena Bioscience Basic Information, Manufacturing Base and Competitors
Table 4. Jena Bioscience Major Business
Table 5. Jena Bioscience Labeled Nucleotides Product and Services
Table 6. Jena Bioscience Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Yumpu Basic Information, Manufacturing Base and Competitors
Table 8. Yumpu Major Business
Table 9. Yumpu Labeled Nucleotides Product and Services
Table 10. Yumpu Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CJ CheilJedang Corporation Basic Information, Manufacturing Base and Competitors
Table 12. CJ CheilJedang Corporation Major Business
Table 13. CJ CheilJedang Corporation Labeled Nucleotides Product and Services
Table 14. CJ CheilJedang Corporation Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Star Lake Bioscience Basic Information, Manufacturing Base and Competitors
Table 16. Star Lake Bioscience Major Business
Table 17. Star Lake Bioscience Labeled Nucleotides Product and Services
Table 18. Star Lake Bioscience Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. ThermoFisher Scientific Basic Information, Manufacturing Base and Competitors
Table 20. ThermoFisher Scientific Major Business
Table 21. ThermoFisher Scientific Labeled Nucleotides Product and Services
Table 22. ThermoFisher Scientific Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Meihua Group Basic Information, Manufacturing Base and Competitors
Table 24. Meihua Group Major Business
Table 25. Meihua Group Labeled Nucleotides Product and Services
Table 26. Meihua Group Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 28. F. Hoffmann-La Roche Major Business
Table 29. F. Hoffmann-La Roche Labeled Nucleotides Product and Services
Table 30. F. Hoffmann-La Roche Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biorigin Basic Information, Manufacturing Base and Competitors
Table 32. Biorigin Major Business
Table 33. Biorigin Labeled Nucleotides Product and Services
Table 34. Biorigin Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. DSM Nutritional Products Basic Information, Manufacturing Base and Competitors
Table 36. DSM Nutritional Products Major Business
Table 37. DSM Nutritional Products Labeled Nucleotides Product and Services
Table 38. DSM Nutritional Products Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Promega Corporation Major Business
Table 41. Promega Corporation Labeled Nucleotides Product and Services
Table 42. Promega Corporation Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Affymetrix Basic Information, Manufacturing Base and Competitors
Table 44. Affymetrix Major Business
Table 45. Affymetrix Labeled Nucleotides Product and Services
Table 46. Affymetrix Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 48. Agilent Technologies Major Business
Table 49. Agilent Technologies Labeled Nucleotides Product and Services
Table 50. Agilent Technologies Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Lallemand Basic Information, Manufacturing Base and Competitors
Table 52. Lallemand Major Business
Table 53. Lallemand Labeled Nucleotides Product and Services
Table 54. Lallemand Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Nanjing BioTogether Basic Information, Manufacturing Base and Competitors
Table 56. Nanjing BioTogether Major Business
Table 57. Nanjing BioTogether Labeled Nucleotides Product and Services
Table 58. Nanjing BioTogether Labeled Nucleotides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Labeled Nucleotides Sales by Manufacturer (2019-2021e) & (K MT)
Table 60. Global Labeled Nucleotides Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Labeled Nucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Labeled Nucleotides Production Capacity by Company, (K MT): 2020 VS 2021
Table 63. Head Office and Labeled Nucleotides Production Site of Key Manufacturer
Table 64. Global Labeled Nucleotides Sales by Region (2016-2021e) & (K MT)
Table 65. Global Labeled Nucleotides Sales by Region (2021-2026) & (K MT)
Table 66. Global Labeled Nucleotides Revenue by Region (2016-2021e) & (USD Million)
Table 67. Global Labeled Nucleotides Revenue by Region (2021-2026) & (USD Million)
Table 68. Global Labeled Nucleotides Sales by Type (2016-2021e) & (K MT)
Table 69. Global Labeled Nucleotides Sales by Type (2021-2026) & (K MT)
Table 70. Global Labeled Nucleotides Revenue by Type (2016-2021e) & (USD Million)
Table 71. Global Labeled Nucleotides Revenue by Type (2021-2026) & (USD Million)
Table 72. Global Labeled Nucleotides Price by Type (2016-2021e) & (USD/MT)
Table 73. Global Labeled Nucleotides Price by Type (2021-2026) & (USD/MT)
Table 74. Global Labeled Nucleotides Sales by Application (2016-2021e) & (K MT)
Table 75. Global Labeled Nucleotides Sales by Application (2021-2026) & (K MT)
Table 76. Global Labeled Nucleotides Revenue by Application (2016-2021e) & (USD Million)
Table 77. Global Labeled Nucleotides Revenue by Application (2021-2026) & (USD Million)
Table 78. Global Labeled Nucleotides Price by Application (2016-2021e) & (USD/MT)
Table 79. Global Labeled Nucleotides Price by Application (2021-2026) & (USD/MT)
Table 80. North America Labeled Nucleotides Sales by Country (2016-2021e) & (K MT)
Table 81. North America Labeled Nucleotides Sales by Country (2021-2026) & (K MT)
Table 82. North America Labeled Nucleotides Revenue by Country (2016-2021e) & (USD Million)
Table 83. North America Labeled Nucleotides Revenue by Country (2021-2026) & (USD Million)
Table 84. North America Labeled Nucleotides Sales by Type (2016-2021e) & (K MT)
Table 85. North America Labeled Nucleotides Sales by Type (2021-2026) & (K MT)
Table 86. North America Labeled Nucleotides Sales by Application (2016-2021e) & (K MT)
Table 87. North America Labeled Nucleotides Sales by Application (2021-2026) & (K MT)
Table 88. Europe Labeled Nucleotides Sales by Country (2016-2021e) & (K MT)
Table 89. Europe Labeled Nucleotides Sales by Country (2021-2026) & (K MT)
Table 90. Europe Labeled Nucleotides Revenue by Country (2016-2021e) & (USD Million)
Table 91. Europe Labeled Nucleotides Revenue by Country (2021-2026) & (USD Million)
Table 92. Europe Labeled Nucleotides Sales by Type (2016-2021e) & (K MT)
Table 93. Europe Labeled Nucleotides Sales by Type (2021-2026) & (K MT)
Table 94. Europe Labeled Nucleotides Sales by Application (2016-2021e) & (K MT)
Table 95. Europe Labeled Nucleotides Sales by Application (2021-2026) & (K MT)
Table 96. Asia-Pacific Labeled Nucleotides Sales by Region (2016-2021e) & (K MT)
Table 97. Asia-Pacific Labeled Nucleotides Sales by Region (2021-2026) & (K MT)
Table 98. Asia-Pacific Labeled Nucleotides Revenue by Region (2016-2021e) & (USD Million)
Table 99. Asia-Pacific Labeled Nucleotides Revenue by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Labeled Nucleotides Sales by Type (2016-2021e) & (K MT)
Table 101. Asia-Pacific Labeled Nucleotides Sales by Type (2021-2026) & (K MT)
Table 102. Asia-Pacific Labeled Nucleotides Sales by Application (2016-2021e) & (K MT)
Table 103. Asia-Pacific Labeled Nucleotides Sales by Application (2021-2026) & (K MT)
Table 104. South America Labeled Nucleotides Sales by Country (2016-2021e) & (K MT)
Table 105. South America Labeled Nucleotides Sales by Country (2021-2026) & (K MT)
Table 106. South America Labeled Nucleotides Revenue by Country (2016-2021e) & (USD Million)
Table 107. South America Labeled Nucleotides Revenue by Country (2021-2026) & (USD Million)
Table 108. South America Labeled Nucleotides Sales by Type (2016-2021e) & (K MT)
Table 109. South America Labeled Nucleotides Sales by Type (2021-2026) & (K MT)
Table 110. South America Labeled Nucleotides Sales by Application (2016-2021e) & (K MT)
Table 111. South America Labeled Nucleotides Sales by Application (2021-2026) & (K MT)
Table 112. Middle East & Africa Labeled Nucleotides Sales by Country (2016-2021e) & (K MT)
Table 113. Middle East & Africa Labeled Nucleotides Sales by Country (2021-2026) & (K MT)
Table 114. Middle East & Africa Labeled Nucleotides Revenue by Country (2016-2021e) & (USD Million)
Table 115. Middle East & Africa Labeled Nucleotides Revenue by Country (2021-2026) & (USD Million)
Table 116. Middle East & Africa Labeled Nucleotides Sales by Type (2016-2021e) & (K MT)
Table 117. Middle East & Africa Labeled Nucleotides Sales by Type (2021-2026) & (K MT)
Table 118. Middle East & Africa Labeled Nucleotides Sales by Application (2016-2021e) & (K MT)
Table 119. Middle East & Africa Labeled Nucleotides Sales by Application (2021-2026) & (K MT)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Labeled Nucleotides Typical Distributors
Table 123. Labeled Nucleotides Typical Customers
List of Figures
Figure 1. Labeled Nucleotides Picture
Figure 2. Global Labeled Nucleotides Sales Market Share by Type in 2020
Figure 3. TaqMan Allelic Discrimination
Figure 4. Gene Chips & Microarrays
Figure 5. SNP by Pyrosequencing
Figure 6. Global Labeled Nucleotides Sales Market Share by Application in 2020
Figure 7. Hospital Laboratories
Figure 8. Reference Laboratories
Figure 9. Academic Research Laboratories
Figure 10. Other Laboratories
Figure 11. Global Labeled Nucleotides Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Labeled Nucleotides Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Labeled Nucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Labeled Nucleotides Sales (2016-2026) & (K MT)
Figure 33. Global Labeled Nucleotides Production Capacity (2016-2026) & (K MT)
Figure 34. Global Labeled Nucleotides Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Labeled Nucleotides Market Drivers
Figure 36. Labeled Nucleotides Market Restraints
Figure 37. Labeled Nucleotides Market Trends
Figure 38. Global Labeled Nucleotides Sales Market Share by Manufacturer in 2020
Figure 39. Global Labeled Nucleotides Revenue Market Share by Manufacturer in 2020
Figure 40. Labeled Nucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Labeled Nucleotides Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Labeled Nucleotides Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Labeled Nucleotides Sales Market Share by Region (2016-2026)
Figure 44. Global Labeled Nucleotides Revenue Market Share by Region (2016-2026)
Figure 45. North America Labeled Nucleotides Revenue (2016-2026) & (USD Million)
Figure 46. Europe Labeled Nucleotides Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Labeled Nucleotides Revenue (2016-2026) & (USD Million)
Figure 48. South America Labeled Nucleotides Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Labeled Nucleotides Revenue (2016-2026) & (USD Million)
Figure 50. Global Labeled Nucleotides Sales Market Share by Type (2016-2026)
Figure 51. Global Labeled Nucleotides Revenue Market Share by Type (2016-2026)
Figure 52. Global Labeled Nucleotides Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Labeled Nucleotides Sales Market Share by Application (2016-2026)
Figure 54. Global Labeled Nucleotides Revenue Market Share by Application (2016-2026)
Figure 55. Global Labeled Nucleotides Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Labeled Nucleotides Sales Market Share by Country (2016-2026)
Figure 57. North America Labeled Nucleotides Revenue Market Share by Country (2016-2026)
Figure 58. North America Labeled Nucleotides Sales Market Share by Type (2016-2026)
Figure 59. North America Labeled Nucleotides Sales Market Share by Application (2016-2026)
Figure 60. Europe Labeled Nucleotides Sales Market Share by Country (2016-2026)
Figure 61. Europe Labeled Nucleotides Revenue Market Share by Country (2016-2026)
Figure 62. Europe Labeled Nucleotides Sales Market Share by Type (2016-2026)
Figure 63. Europe Labeled Nucleotides Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Labeled Nucleotides Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Labeled Nucleotides Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Labeled Nucleotides Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Labeled Nucleotides Sales Market Share by Application (2016-2026)
Figure 68. South America Labeled Nucleotides Sales Market Share by Country (2016-2026)
Figure 69. South America Labeled Nucleotides Revenue Market Share by Country (2016-2026)
Figure 70. South America Labeled Nucleotides Sales Market Share by Type (2016-2026)
Figure 71. South America Labeled Nucleotides Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Labeled Nucleotides Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Labeled Nucleotides Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Labeled Nucleotides Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Labeled Nucleotides Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source